EADV 2024 Interview: Branka Marinović
This is one field of dermatology that, in the last 20 years, developed very rapidly in the field of diagnostic methods, but also in the…
Related Articles
Additional Evidence Supports Quoin’s QRX003 for Netherton Syndrome
QRX003 mimics the LEKTI protein to strengthen skin barriers and alleviate symptoms in patients with Netherton Syndrome.
James Del Rosso, DO, on What’s New in the Medicine Chest
In his presentation at Winter Clinical Miami, Del Rosso covered new and emerging therapies as well as successful off-label uses.
Immune Triggers Linked to Chronic Pruritus and Elevated Type 2 Inflammation
New findings uncover the role of immune triggers, including vaccines and therapies, in chronic pruritus and its association with heightened type 2 inflammation markers.
Serum Immunoglobulin G Levels and Nicastrin Variation in Hidradenitis Suppurativa
This cross-sectional study examines the association between serum immunoglobulin G levels and underlying nicastrin variation in individuals with hidradenitis suppurativa.
Improving Anaphylaxis Diagnosis with Trigger-Specific Findings
Recognising anaphylaxis triggers enhances diagnosis and management, offering faster, targeted treatment in emergency settings.
Combining Minoxidil and LLLT Does Not Improve Treatment Outcomes for Androgenic Alopecia
Compared to minoxidil alone, the combination therapy saw no significant differences in hair count and diameter.
Exploring Oral Therapies for Hyperhidrosis: Current and Future Perspectives
Adam Friedman, MD, FAAD, takes a closer look at the emerging landscape of oral treatments for hyperhidrosis and what lies ahead in advancing patient care.
Acne Relapse and Isotretinoin Retrial in Patients With Acne
This cohort study assess rates of acne relapse and isotretinoin retrial and identifies associated factors in patients after completing an isotretinoin course.
Hema Now: Episode 9: A Conversation with the EBMT President
Anna Sureda, Institut Català d’Oncologia – Hospital Duran i Reynals, Barcelona, Spain and President of the EBMT joins the EMJ podcast
